Nanofat Cell-Mediated Anti-Aging Therapy: Evidence-Based Analysis of Efficacy and an Update of Stem Cell Facelift
- PMID: 34085105
- DOI: 10.1007/s00266-021-02353-w
Nanofat Cell-Mediated Anti-Aging Therapy: Evidence-Based Analysis of Efficacy and an Update of Stem Cell Facelift
Abstract
Background: Fat grafting has been extensively applied as natural filler and has been very promising in restoring volume loss. Lipografting has also been credited to reduce age-related skin changes due to the regenerative potential of adipose derived stem cells. Cell-mediated therapies in plastic surgery are rapidly evolving with growing applications. Nanofat, a bio-regenerative liquid suspension rich in stromal vascular fraction cells without viable adipocytes, has been described as an efficient cutaneous anti-aging therapy. We have published in 2013 a review entitled "stem cell facelift: between reality and fiction." Available clinical evidence at that time did not substantiate marketing and promotional claims of "stem cell facelift". The same year, the report about nanofat was published demonstrating striking clinical outcome. The current literature search is aimed at reviewing any evidence that has emerged since then regarding clinical efficacy of this modality.
Methods: A thorough PICO tool-based comprehensive literature search of PubMed database for "the efficacy of nanofat cell-mediated anti-aging therapy" was conducted with a time frame from 2013 till present.
Results: Despite apparent increasing popularity of stem cell rejuvenation, well-controlled clinical studies about this modality are surprisingly very scarce. Only seven papers published after 2013 were identified and were included in this review CONCLUSION: Though considered to be a safe procedure, and despite documented histologic improvement and striking clinical outcome in some reports, available evidence can hardly support clinical improvement of skin quality. Before cell-mediated aesthetic rejuvenation applications can be routinely undertaken, more robust evidence with well-defined primary outcome end points and objective outcome measures is required.
Level of evidence: IV.
Keywords: Adipose derived stem cells (ADSCs); Cell-mediated therapy; Mesenchymal cells (MCs); Nanofat; Rejuvenation; Stromal vascular fraction (SVF).
© 2021. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.
Comment in
-
Invited Discussion on: "Nanofat Cell-Mediated Anti-Aging Therapy: Evidence-Based Analysis of Efficacy and an Update of Stem Cell Facelift" by Bishara Atiyeh, Fadi Ghieh, Ahmad Oneisi.Aesthetic Plast Surg. 2021 Dec;45(6):2948-2951. doi: 10.1007/s00266-021-02572-1. Epub 2021 Sep 16. Aesthetic Plast Surg. 2021. PMID: 34529105 No abstract available.
References
-
- Xu Y, Deng M, Cai Y, Zheng H et al (2020) Cell-free fat extract increases dermal thickness by enhancing angiogenesis and extracellular matrix production in nude mice. Aesthet Surg J 40(8):904–913 - PubMed
-
- Fournier PF (1990) Facial recontouring with fat grafting. Dermatol Clin 8(3):523–537 - PubMed
-
- Coleman SR (1995) Long-Term survival of fat transplants: controlled demonstrations. Aesthet Plast Surg 19(5):421–425
-
- Pourang A, Rockwell H, Karimi K (2020) New frontiers in skin rejuvenation, including stem cells and autologous therapies. Fac Plast Surg Clin 28(1):101–117
-
- Bianchi F, Maioli M, Leonardi E, Olivi E et al (2013) A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transpl 22(11):2063–2077
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
